Life sciences news
-
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Thursday July 15th 2021
Read more
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Thursday July 15th 2021
Read more
-
eTheRNA immunotherapies and Ghent University announce mRNA Delivery Collaboration and License Agreement
Tuesday July 13th 2021
Read more
-
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis
Monday July 12th 2021
Read more
-
Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer
Monday July 12th 2021
Read more
-
Biotalys completes its €47.5m initial public offering on Euronext Brussel
Wednesday July 7th 2021
Read more
-
Biotalys appoints Markus Heldt as Independent Director
Tuesday July 6th 2021
Read more
-
eureKARE and DNAlytics establish partnership to develop a proprietary AI platform
Tuesday July 6th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Vacature: Co General Manager flanders.bio
Tuesday July 6th 2021
Read more
-
flanders.bio looks with confidence to the future after a year with different key milestones – the organisation sets new objectives and announces changes in senior leadership
Monday July 5th 2021
Read more
-
AgomAb Therapeutics expands senior team with General Counsel and Head of Clinical Operations
Friday July 2nd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
